glp 1 drugs for pcos GLP-1 medications are not approved by the Food and Drug Administration to treat polyendocrine metabolic ovarian syndrome (PMOS), the condition renamed from polycystic ovary syndrome in 2026. Because the use is off-label Women with a common hormonal

Calms inflammation and supports skin repair Its anti-inflammatory properties help calm irritation, redness, and swelling

Cystathionine is then broken down by cystathionine gamma-lyase (CGL) to form cysteine

But the body can convert synthetic forms into natural ones

In September 2023, the FDA classified BPC-157 as a Category 2 compound under the 503A bulking list, restricting its use by American compounding pharmacies

The resulting stress may affect mitochondrial energy, antioxidant defense, neurotransmitter regulation, sleep, cognition and medication tolerance

Learn more about our editorial standards and meet the medical team